Biblio

Found 4 results

Author Keyword Title Type [ Year

]

Filters: Author is Alain G Zeimet [Clear All Filters]

2015

S. Mahner, Meier, W., du Bois, A., Brown, C., Lorusso, D., Dell'Anna, T., Cretin, J., Havsteen, H., Bessette, P., Zeimet, A. G., Vergote, I. B., Vasey, P. A., Pujade-Lauraine, E., Gladieff, L., and Ferrero, A., “Carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in very platinum-sensitive ovarian cancer patients: results from a subset analysis of the CALYPSO phase III trial.”, Eur J Cancer, vol. 51, no. 3, pp. 352-8, 2015.

2011

M. Leonard Friedlander, Trimble, E. L., Tinker, A., Alberts, D. S., Åvall-Lundqvist, E., Brady, M. F., Harter, P., Pignata, S., Pujade-Lauraine, E., Sehouli, J., Vergote, I. B., Beale, P., Bekkers, R., Calvert, P., Copeland, L., Glasspool, R. M., Gonzalez-Martin, A., Katsaros, D., Kim, J. Won, Miller, B., Provencher, D. M., Rubinstein, L., Atri, M., Zeimet, A. G., Bacon, M., Kitchener, H. C., and Stuart, G. C. E., “Clinical trials in recurrent ovarian cancer.”, Int J Gynecol Cancer, vol. 21, no. 4, pp. 771-5, 2011.

2008

E. Åvall-Lundqvist, Wimberger, P., Gladieff, L., Gebski, V., Huober, J., Floquet, A., Fitzharris, B., Zeimet, A. G., Heywood, M., and Schmalfeldt, B., “Pegylated liposomal doxorubicin-carboplatin vs paclitaxel-carboplatin in relapsing sensitive ovarian cancer: a 500-patient interim safety analysis of the CALYPSO GCIG intergroup phase III study. ”, Proc.Am.Soc.Clin.Oncol. , vol. 26, no. 15S Part I, 2008.

2006

E. Petru, Angleitner-Boubenizek, L., Reinthaller, A., Deibl, M., Zeimet, A. G., Volgger, B., Stempfl, A., and Marth, C., “Combined PEG liposomal doxorubicin and gemcitabine are active and have acceptable toxicity in patients with platinum-refractory and -resistant ovarian cancer after previous platinum-taxane therapy: a phase II Austrian AGO study”, Gynecol Oncol, vol. 102, pp. 226-9, 2006.